» Articles » PMID: 39822418

Role of Psychological Factors in Migraine

Overview
Journal Cureus
Date 2025 Jan 17
PMID 39822418
Authors
Affiliations
Soon will be listed here.
Abstract

Migraine, marked by moderate to severe headaches, is frequently accompanied by reversible neurological symptoms. Recent studies have revealed a complex and significant relationship between psychological factors and the onset and progression of migraine. Personality traits, such as neuroticism and harm avoidance, play a crucial role in the development, progression, and treatment outcomes of migraines. Migraine patients often experience comorbid mental health conditions, such as depression and anxiety, which contribute to a diminished quality of life by exacerbating migraine-related disability and impaired occupational functioning. In particular, high levels of pain catastrophizing and anxiety sensitivity in migraine sufferers reflect their negative cognitive beliefs, which are closely linked to both their personality traits and vulnerability to mental disorders. This article explores the pathophysiological mechanisms underlying the relationship between migraine and psychological factors, including genetic influences, overlapping brain regions, 5-hydroxytryptamine (5-HT) dysfunction, and neurogenic inflammation. While traditional pharmacological treatments for migraine are often influenced by psychological factors and may have limited efficacy, psychotherapy, such as cognitive behavioral therapy and positive thinking therapy, has been increasingly recognized for its role in alleviating the psychological symptoms associated with migraine and enhancing overall therapeutic outcomes.

References
1.
Hesdorffer D . Comorbidity between neurological illness and psychiatric disorders. CNS Spectr. 2016; 21(3):230-8. DOI: 10.1017/S1092852915000929. View

2.
Seminowicz D, Burrowes S, Kearson A, Zhang J, Krimmel S, Samawi L . Enhanced mindfulness-based stress reduction in episodic migraine: a randomized clinical trial with magnetic resonance imaging outcomes. Pain. 2020; 161(8):1837-1846. PMC: 7487005. DOI: 10.1097/j.pain.0000000000001860. View

3.
Setiawan E, Attwells S, Wilson A, Mizrahi R, Rusjan P, Miler L . Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study. Lancet Psychiatry. 2018; 5(4):339-347. DOI: 10.1016/S2215-0366(18)30048-8. View

4.
. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1789-1858. PMC: 6227754. DOI: 10.1016/S0140-6736(18)32279-7. View

5.
Mose L, Pedersen S, Debrabant B, Jensen R, Gram B . The role of personality, disability and physical activity in the development of medication-overuse headache: a prospective observational study. J Headache Pain. 2018; 19(1):39. PMC: 5970129. DOI: 10.1186/s10194-018-0863-1. View